P, S., JM, V., HK, O., C, Z., TD, S., Y, K., . . . P, L. (2022). Real-world outcomes with ipilimumab and nivolumab in advanced melanoma: A multicentre retrospective study. European journal of cancer (Oxford, England : 1990), 176, 121. https://doi.org/10.1016/j.ejca.2022.09.004
Chicago Style (17th ed.) CitationP, Serra-Bellver, et al. "Real-world Outcomes with Ipilimumab and Nivolumab in Advanced Melanoma: A Multicentre Retrospective Study." European Journal of Cancer (Oxford, England : 1990) 176 (2022): 121. https://doi.org/10.1016/j.ejca.2022.09.004.
MLA (9th ed.) CitationP, Serra-Bellver, et al. "Real-world Outcomes with Ipilimumab and Nivolumab in Advanced Melanoma: A Multicentre Retrospective Study." European Journal of Cancer (Oxford, England : 1990), vol. 176, 2022, p. 121, https://doi.org/10.1016/j.ejca.2022.09.004.